• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-12和白细胞介素-23:固有免疫和适应性免疫的主要调节因子。

IL-12 and IL-23: master regulators of innate and adaptive immunity.

作者信息

Langrish Claire L, McKenzie Brent S, Wilson Nicholas J, de Waal Malefyt Rene, Kastelein Robert A, Cua Daniel J

机构信息

Discovery Research, DNAX Research Inc., Palo Alto, CA 94304, USA.

出版信息

Immunol Rev. 2004 Dec;202:96-105. doi: 10.1111/j.0105-2896.2004.00214.x.

DOI:10.1111/j.0105-2896.2004.00214.x
PMID:15546388
Abstract

Initiation of an effective immune response requires close interactions between innate and adaptive immunity. Recent advances in the field of cytokine biology have led to an increased understanding of how myeloid cell-derived factors regulate the immune system to protect the host from infections and prevent tumor development. In this review, we focus on the function of interleukin (IL)-23, a new member of the IL-12 family of regulatory cytokines produced by activated macrophages and dendritic cells. We propose that IL-12 and IL-23 promote two distinct immunological pathways that have separate but complementary functions. IL-12 is required for antimicrobial responses to intracellular pathogens, whereas IL-23 is likely to be important for the recruitment and activation of a range of inflammatory cells that is required for the induction of chronic inflammation and granuloma formation. These two cytokines work in concert to regulate cellular immune responses critical for host defense and tumor suppression.

摘要

有效的免疫反应的启动需要固有免疫和适应性免疫之间的密切相互作用。细胞因子生物学领域的最新进展使人们对髓样细胞衍生因子如何调节免疫系统以保护宿主免受感染和预防肿瘤发展有了更多的了解。在本综述中,我们重点关注白细胞介素(IL)-23的功能,它是由活化的巨噬细胞和树突状细胞产生的IL-12调节细胞因子家族的新成员。我们提出,IL-12和IL-23促进两种不同的免疫途径,它们具有各自独立但互补的功能。IL-12是针对细胞内病原体的抗菌反应所必需的,而IL-23可能对于诱导慢性炎症和肉芽肿形成所需的一系列炎症细胞的募集和激活很重要。这两种细胞因子协同作用,调节对宿主防御和肿瘤抑制至关重要的细胞免疫反应。

相似文献

1
IL-12 and IL-23: master regulators of innate and adaptive immunity.白细胞介素-12和白细胞介素-23:固有免疫和适应性免疫的主要调节因子。
Immunol Rev. 2004 Dec;202:96-105. doi: 10.1111/j.0105-2896.2004.00214.x.
2
Effects of IL-12 and IL-23 on antigen-presenting cells at the interface between innate and adaptive immunity.白细胞介素-12和白细胞介素-23对天然免疫与适应性免疫交界处抗原呈递细胞的影响。
Crit Rev Immunol. 2002;22(5-6):373-90.
3
Differential macrophage expression of IL-12 and IL-23 upon innate immune activation defines rat autoimmune susceptibility.先天性免疫激活后白细胞介素-12和白细胞介素-23在巨噬细胞中的差异表达决定了大鼠自身免疫易感性。
J Leukoc Biol. 2004 Dec;76(6):1118-24. doi: 10.1189/jlb.0704385. Epub 2004 Sep 15.
4
Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4.白细胞介素-12和白细胞介素-23信号传导以及信号转导和转录激活因子4的免疫调节作用。
Immunol Rev. 2004 Dec;202:139-56. doi: 10.1111/j.0105-2896.2004.00211.x.
5
Rationale and safety of anti-interleukin-23 and anti-interleukin-17A therapy.抗白细胞介素-23和抗白细胞介素-17A疗法的原理及安全性
Curr Opin Infect Dis. 2006 Jun;19(3):245-52. doi: 10.1097/01.qco.0000224818.42729.67.
6
Targeting IL-23 in autoimmunity.在自身免疫中靶向白细胞介素-23。
Curr Opin Investig Drugs. 2005 May;6(5):489-95.
7
STAT3 and its activators in intestinal defense and mucosal homeostasis.STAT3 及其激活物在肠道防御和黏膜稳态中的作用。
Curr Opin Gastroenterol. 2010 Mar;26(2):109-15. doi: 10.1097/MOG.0b013e3283365279.
8
Control of human host immunity to mycobacteria.人类宿主对分枝杆菌免疫的控制。
Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):53-64. doi: 10.1016/j.tube.2004.09.011. Epub 2004 Dec 31.
9
IL-12 receptor deficiency revisited: IL-23-mediated signaling is also impaired in human genetic IL-12 receptor beta1 deficiency.重新审视白细胞介素-12受体缺陷:在人类遗传性白细胞介素-12受体β1缺陷中,白细胞介素-23介导的信号传导也受损。
Eur J Immunol. 2003 Dec;33(12):3393-7. doi: 10.1002/eji.200324343.
10
Biology of IL-21 and the IL-21 receptor.白细胞介素-21及白细胞介素-21受体的生物学特性
Immunol Rev. 2004 Dec;202:84-95. doi: 10.1111/j.0105-2896.2004.00201.x.

引用本文的文献

1
Treatment of Advanced NSCLC Patients with an Anti-Idiotypic NeuGcGM3-Based Vaccine: Immune Correlates in Long-Term Survivors.用基于抗独特型神经节苷脂GM3的疫苗治疗晚期非小细胞肺癌患者:长期存活者的免疫相关性
Biomedicines. 2025 May 6;13(5):1122. doi: 10.3390/biomedicines13051122.
2
The ubiquitin-like modifier FAT10 does not affect IL-12 expression and signaling.类泛素修饰因子FAT10不影响白细胞介素-12的表达和信号传导。
PLoS One. 2025 May 6;20(5):e0323005. doi: 10.1371/journal.pone.0323005. eCollection 2025.
3
The role of chemokines and interleukins in acute lymphoblastic leukemia: a systematic review.
趋化因子和白细胞介素在急性淋巴细胞白血病中的作用:一项系统综述
J Appl Biomed. 2024 Dec;22(4):165-184. doi: 10.32725/jab.2024.024. Epub 2024 Dec 4.
4
Rationale and concerns for using JAK inhibitors in axial spondyloarthritis.在轴性脊柱关节炎中使用JAK抑制剂的基本原理及相关问题
Rheumatol Adv Pract. 2024 Nov 7;8(4):rkae141. doi: 10.1093/rap/rkae141. eCollection 2024.
5
Observations on the efficacy of edaravone dexborneol in preventing post-stroke depression and its inflammatory mechanism: a prospective, randomized, control trial.依达拉奉右莰醇预防脑卒中后抑郁的疗效及其炎症机制观察:一项前瞻性、随机对照试验。
Front Neurosci. 2024 Sep 9;18:1451060. doi: 10.3389/fnins.2024.1451060. eCollection 2024.
6
Cytokines in gingivitis and periodontitis: from pathogenesis to therapeutic targets.龈炎和牙周炎中的细胞因子:从发病机制到治疗靶点。
Front Immunol. 2024 Aug 26;15:1435054. doi: 10.3389/fimmu.2024.1435054. eCollection 2024.
7
Augmenting the Antitumor Efficacy of Natural Killer Cells via SynNotch Receptor Engineering for Targeted IL-12 Secretion.通过合成Notch受体工程靶向分泌白细胞介素-12增强自然杀伤细胞的抗肿瘤功效
Curr Issues Mol Biol. 2024 Mar 28;46(4):2931-2945. doi: 10.3390/cimb46040183.
8
Effect of Intra-ovarian Injection of Mesenchymal Stem Cells or its Conditioned Media on Repeated OPU-IVEP Outcomes in Jersey Heifers and Its Relationship with Follicular Fluid Inflammatory Markers.卵巢内注射间充质干细胞或其条件培养基对泽西小母牛重复超数排卵-体外胚胎生产结果的影响及其与卵泡液炎症标志物的关系
Avicenna J Med Biotechnol. 2024 Jan-Mar;16(1):16-28. doi: 10.18502/ajmb.v16i1.14167.
9
The Efficacy and Safety of Biologics in Treating Ankylosing Spondylitis and Their Impact on Quality of Life and Comorbidities: A Literature Review.生物制剂治疗强直性脊柱炎的疗效与安全性及其对生活质量和合并症的影响:一项文献综述
Cureus. 2024 Mar 3;16(3):e55459. doi: 10.7759/cureus.55459. eCollection 2024 Mar.
10
XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors as Evidenced by Preclinical Studies.XTX301,一种肿瘤激活的白细胞介素-12,具有拓宽白细胞介素 12 治疗实体瘤治疗指数的潜力,这一点已被临床前研究证明。
Mol Cancer Ther. 2024 Apr 2;23(4):421-435. doi: 10.1158/1535-7163.MCT-23-0336.